Eli Lilly Goodwill and Intangible Assets 2010-2024 | LLY

Eli Lilly goodwill and intangible assets for the quarter ending September 30, 2024 were $12.306B, a 13.24% increase year-over-year.

  • Eli Lilly goodwill and intangible assets for 2023 were $11.846B, a 5.02% increase from 2022.
  • Eli Lilly goodwill and intangible assets for 2022 were $11.28B, a 2.63% decline from 2021.
  • Eli Lilly goodwill and intangible assets for 2021 were $11.584B, a 3.28% increase from 2020.

Eli Lilly Goodwill and Intangible Assets 2010-2024 | LLY

  • Eli Lilly goodwill and intangible assets for 2023 were $11.846B, a 5.02% increase from 2022.
  • Eli Lilly goodwill and intangible assets for 2022 were $11.28B, a 2.63% decline from 2021.
  • Eli Lilly goodwill and intangible assets for 2021 were $11.584B, a 3.28% increase from 2020.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B